BPI Kiosk

In BPI kiosk is published by the BPI e. V. publications.

In BPI kiosk is organized by the Federal Association of the Pharmaceutical Industry (BPI) e. V. published publications.

These include:

• pharmaceutical data - Important facts about the industry and the health care system at a glance

• Pharma Report - the newsletter of the pharmaceutical industry

• Position Papers

• guides

• Other publications

The content of the kiosk is supplemented by the latest publications of the BPI regularly.

Selected publications can be found here in English.

Individual Publications in detail:

Pharmaceutical data

In the annually published "pharmaceutical data" of the BPI the key figures of the pharmaceutical industry and health care are compressed together. Topics range from the analysis of the national and international market, on issues of drug use and drug safety to legal aspects as well as information for pharmaceutical research and development and the increasingly growing in importance the field of biotechnology and genetic engineering.

Pharma Report

Through the newsletter, the general public can not only up to date information on the views of the pharmaceutical industry on health policy but also on companies and professional backgrounds.

About the BPI

The Federal Association of the Pharmaceutical Industry e. V. (BPI) represents with its more than 65-year experience in the field of drug research, development, -approved, manufacturing and marketing a wide spectrum of the pharmaceutical industry at the national and international levels. Around 250 companies with about 78,000 employees have joined together in BPI. These include classic pharmaceutical companies, pharmaceutical service company in the field of biotechnology, herbal medicine and homeopathy / anthroposophy.

The aim of the BPI is to advance the health future. He is deeply involved in the health policy reform debate. To ensure that patients receive the correct essential medicine and therapies, the association is committed to safeguarding the diversity of quality-oriented drug therapy all directions. For this purpose, the BPI is in continuous dialogue with the other partners of the health care and the public.

As a modern association of BPI is equally service organization and represents the interests of its member companies. According to its diverse activities it occupies among other fields of competence drug safety, biotechnology, disinfectants, homeopathy / anthroposophy, innovation and research, clinical research, communications, business development, herbal medicines, politics, law, self-medication and the national authorization and approval in Europe.